Introduction

The anatomic abnormalities are observed in developmental dysplasia of the hip (DDH) and it is challenging to perform the total hip arthroplasty (THA) for some DDH patients. If acetabular cup was placed at the original acetabular position in patients with high hip dislocation, it may be difficult to perform reduction of hip prosthesis because of soft tissue contracture. The procedures resolving this problem were to use femoral shortening osteotomy, or to place the acetabular cup at a higher cup position than the original hip center. Femoral shortening osteotomy has some concerns about its complicated procedure, time consuming, and risk of non-union. Conversely, implantation of the acetabular cup at the higher cup position may eliminate these shortcomings and this procedure is considered to be preferred if possible. However, the criteria of cases without femoral shortening osteotomy are not clear. In this study, we retrospectively analysed the clinical outcomes of patients performed THAs for high hip dislocation, and clarified the adaptation of THA with or without femoral shortening osteotomy.

INTRODUCTION

To obtain appropriate joint gap and soft tissue balance, and to correct the lower limb alignment are important factor to achieve success of total knee arthroplasty (TKA). A variety of computer-assisted navigation systems have been developed to implant the component accurately during TKA. Although, the effects of the navigation system on the joint gap and soft tissue balance are unclear. The purpose of the present study was to investigate the influence of accelerometer-based portable navigation system on the intraoperative joint gap and soft tissue balance.

INTRODUCTION

The concept of anatomical stam is fit-and-fill in the proximity of the femur and to expect wall fixation, following to reduce thigh pain and stress shielding. Although the femoral medullary form and size are different in each races. CentPillar TMZF stem (stryker ^®) is anatomical stem designed based on computer-tomography of Japanese femurs. The purpose of this study was to evaluate clinical and radiographic outcomes of CentPillar TMZF stem at a mean of 3.6 years postoperatively.

The Taperloc Microplasty stem design was based on that of the Taperloc stem with flat tapered wedge and the distal portion of the Taperloc stem was shortened by 35mm.

We report the minimum two-year follow up (mean, 26 months) of 68 primary total hip arthroplasty using the Taperloc Microplasty stem. 39 Magnum acetabular cups and 29 M2a Taper acetabular cups were inserted with metal on metal articulation. The series comprised 67 patients (20 men, 47 women) with a mean age at operation of 65 years (31 to 85). The principal diagnosis was osteosrthritis.

Their mean JOA Hip Score improved significantly from 36 points preoperatively to 96 points at two-year follow up. Radiological asseement showed good bony stability in all implants. There was one case of post operative anterior dislocation. We did not see intra-operative fracture previously reported for this implant. There were no clinical and radiological complications related to MOM articulation.

This short-term follow up study demonstrates that the clinical outcome of the Tapeloc Microplasty stem is comparable with that of standard Taperloc stem and other flat taper wedge stems.

[Background]

Bipolar hemiarthroplasty (following BHA) have historically had poor results in patients with idiopathic osteonecrosis of femoral head (OFNH). However, most recent report have shown excellent results with new generation BHA designs that incorporate advances in bearing technology. These optimal outcomes with bipolar hemiarthroplasty will be more attractive procedure for young patients who need bone stock for future total arthroplasty. The purpose of the current study was to evaluate the clinical and radiographic finding of this procedure for the treatment of OFNH at our institution after 7-to 21years follow-up.

Metal on metal total hip arthroplasty (MoM THA) provides the potential improvement in articular wear. However, several adverse events including pseudotumor had been reported. Magnetic resonance imaging (MRI) was considered to be the proposal tool for detection of pseudotumor after MoM THA. In this study, we performed the screening of pseudotumor after MoM THA using the MRI.

We studied 43 patients with M2a Magnum® (Biomet) and 34 patients with M2a Taper® (Biomet) of MoM THA from December 2009 to December 2011 with follow-up of 2.5 years (2.0–4.0 years) after surgery. MRI assessments were performed at a mean of 2.1 years postoperatively. Pseudotumor findings were graded using Anderson classification (Skeletal Radiol, 2011: 40; 303). Age, sex, height, weight, Harris Hip Score, EQ5D satisfaction score, UCLA activity score, and blood metal ion levels were evaluated.

The prevalence of pseudotumor was 27.2%; 56 normal (Type A), 13 mild (C1), 8 moderate (C2) and none were graded severe (C3). Weight and BMI in the mild group was significantly higher than those in normal. There was no significant difference in age, sex and height among these groups. With regard to Harris Hip score, pain and ROM score in moderate group was significantly lower than that in normal and mild group. EQ5D satisfaction score and UCLA activity score showed not significant differences among groups. 3.01±3.32 μg/L of blood cobalt ion levels in the moderate groups was significantly higher than 0.97±0.64 μg/L in normal group. Blood cobalt ion levels of 1 mild and 2 moderate were over the threshold of 7 μg/L. These patients were implanted with M2a Taper, not M2a Magnum. 14% of the prevalence in the patients with M2a Magnum was significantly lower than 41% in the patients with M2a Taper. No revision surgeries were required.

The patients with no pseudotumor did not show the increase of blood metal ion. Contrarily, several patients showed the increase of blood metal ion in case of detecting pseudotumor. MRI assessments were useful for screening of pseudotumor after MoM THA and blood metal ion should be investigated for patients with mild and moderate pseudotumor in MoM THA.

Modulus femoral prosthesis is a modular cementless femoral system which consists of 5 degree tapered conical stem made of a titanium alloy with 8 fins of 1mm and modular neck. Modular neck enables to control any ideal stem anteversion as a surgeon prefers. This system is considered to be useful in severe hip deformity, for example developmental dysplasia of the hip (DDH). In this study, clinical and radiographic outcomes of the Modulus femoral prosthesis were evaluated at a mean of 3.6 (2–6) years postoperatively.

We assessed the results of 193 primary total hip arthroplasty using a Modulus femoral prosthesis in 169 patients (15 males, 154 females) undergoing surgery between September 2007 and December 2011. The mean age at the time of surgery was 65.6 (31–86) years old. The diagnoses were osteoarthritis (OA) in 178 hips (including 167 hips of DDH), rapidly destructive coxopathy (RDC) in 6 hips, rheumatoid arthritis (RA) in 6 hips, osteonecrosis in 2 hips, and subchondral insufficiency fracture in one hip. Clinical outcomes were assessed using Japan Orthopedic Association (JOA) hip scores and complications. Radiographic assessments were including stem alignment, bone on-growth, cortical hypertrophy, stress shielding and stem subsidence.

43.8 points of the preoperative mean JOA score was significantly improved to 93.1 points postoperatively. In one case intraoperative femoral fracture was occurred. One dislocation had occurred and thigh pain was observed in one hip. No revision surgery was required. In 192 hips of 193 hips (99.5%), stem was implanted in neutral position (within ±2 degrees). Bone on-growth was observed in all cases (94.3% in zone 3; 73.1% in zone 5; 30.6% in zone 2; 22.3% in zone 6). Cortical hypertrophy was observed in 66 hips (34.2%) at zone 3 and 5. Reduction of bone density due to stress shielding was observed (1^st degree was 58.5%; 2^nd degree was 29.5%; 3^rd degree was 11.9%; 4^th degree was 0%). In 22 cases (11.4%), more than 2mm of stem subsidence was observed, however the subsidence was stopped within 6 months in all cases.

Modulus femoral prosthesis showed good clinical results and radiographic findings up to 6 years postoperatively.

Metal on metal total hip arthroplasty provides the potential improvement in articular wear and the use of large-diameter femoral heads following the prospect for reduction in the risk of dislocation. The purpose of this study was to compare the clinical and radiographic outcomes as well as serum metal ion level between the two different component designs with small and large femoral heads in metal on metal total hip arthroplasty.

We studied 39 patients with large head (Magnum®, Biomet; cup size minus 6 mm) and 37 patients with small head (M2a taper®, Biomet; 28 or 32 mm head) of metal on metal total hip arthroplasty between December 2009 to October 2011 with follow-up of 2.1 years (1.0–3.3 years) after surgery. Harris Hip Score, UCLA activity score, EQ-5D, radiographic assessment, and serum cobalt and chromium ion levels were evaluated.

Harris Hip Score, UCLA activity score, and EQ-5D were improved after surgery in small and large head groups, however, no significant differences were observed between both groups. Cup inclination was below 50 degree in all prosthesis. No loosening and no osteolysis were observed. Cobalt and chromium ion was not detected before surgery; however, metal ion levels of both groups were increased after surgery in time dependent manner. There was no significant difference between two groups at one year after surgery. One patient in each group showed the increase of cobalt ion level over 7 ppb (15.4 ppb, 12.9 ppb) without any clinical symptom including pain. Cup inclination was 29 degree in both patients and cup anteversion was 38 and 41 degree, respectively.

There was no significant difference of ion levels between both groups. No dislocation was observed in large head group while one dislocation occurred in small head group. No patients required the revision surgery.

This metal on metal component, especially with large femoral heads, showed the good clinical results at the maximum follow up of 3.3 year after surgery. However, the ion level of two patients increased over 7 ppb and longer follow-up will be needed.

Alendronate is a potent inhibitor of bone resorptive activity, and has been shown to prevent and restore periprosthetic osteolysis in experimental models. A preliminary study was conducted to examine clinical usefulness of a lendronate treatment.

Twenty-five patients (27 hips) with radiological evidence of osteolysis after cemented total hip arthroplasty were included. Of these, 14 patients (15 hips) were administered 5 mg of alendronate daily (alendronate group), and 11 patients (12 hips) did not receive alendronate treatment (control group). The subjects were followed up for 12 months, using radiological examinations and biochemical markers. The radiological analysis was evaluated blindly by 2 joint arthroplasty experts, each with more than 10 years of experience, without knowledge of alendronate administration.

In the alendronate group, average serum bone alkaline phosphatase and urinary excretion of the N-telopep-tide of type I collagen values decreased from the baseline values after administration of alendronate, to 71% and 76% of baseline at the 3-month examination, and 57% and 62% at the 1-year examination, respectively. In the control group, expansion of osteolysis was found in 5 hips (42%) and no hip showed restoration of osteolysis. In the alendronate group, expansion of osteolysiswas found in 2 hips (13%), and restoration of osteolysis was found in 5 hips (33%). There was a statistically significant difference in ratio of hips with osteolysis restoration between the 2 groups (p< 0.05). In the alendronate group, there was no significant difference in age, average linear wear rate of polyethylene, and the biochemical markers, between the hips with and without diminishment of osteolysis.

Conclusions: The present results indicate that clinicala-lendronate treatment can prevent and restore periprosthetic osteolysis, which is generally thought to require surgical intervention. These findings warrant further study of the effects of duration and dose of alendronate treatment, component materials, and component fixation methods.

Introduction: Progression of collapse in osteonecrosis of the femoral head (ONFH) is greatly influenced by repair reactions, especially bone resorptive activity. This study was performed to test if systemic alendronate treatment, a potent inhibitor of osteoclast activity, can prevent the development of collapse in ONFH.

Materials and Methods: Daily administration of oral alendronate (5mg/day) was started in 14 hips in 11 patients with ONFH (Alendronate group). At the beginning of the study (3, 6, 12 months), plain radiographs, T1-weighted MR imaging, and biochemical makers of osteoclast activity (N-telopeptide of type-I collagen) and osteoblast activity (Bone-specific alkaline phosphatase), were examined. At 12 months, MR imaging was repeated. Eleven hips in 6 patients with ONFH who did not receive alendronate administration were considered as the control group.

Results: There was no significant difference with respect to gender distribution, etiology factors, initial ARCO stages, and extent of necrosis in the two groups. In the alendronate group, there was an early decrease of osteoclast activity at 3 months, with a decrease to 62% at 12 months, while the decrease of osteoblast activity was smaller with 80% at 12 months. Development of collapse was observed in 4 of the 11 hips (36%) in the control group, and in none of the 14 hips in the alendronate group. There was a significant difference of collapse development between the two groups (p=0.026, Mann-Whitney U-test). Signal change on serial MR images was observed in 5 of 9 hips (56%) in the control group, with only one of 9 hips (11%) in the alendronate group.

Discussion: The low incidence of signal change on serial MR images may reflect the decrease of repair activity in the alendronate group. The present study was the first clinical trial to show that alendronate has a significant preventive effect of collapse development in patients with osteonecrosis of the femoral head.

Introduction: In order to investigate the relationship between the degeneration of the acetabular cartilage and the radiological staging of osteonecrosis of the femoral head, the following study was performed.

Materials and Methods: Acetabular cartilage with sub-chondral bone was taken from the superior dome from 34 hips from 30 patients undergoing total hip arthroplasty due to osteonecrosis of the femoral head. The specimens were stained with hematoxylineosin and safranin-O, and were evaluated as to the thinning of cartilage, fibrillation, clefts, and proliferation of chondrocytes. There were 18 females and 12 males with an average age of 49 years. We used the radiological staging system proposed by the working group of the Specific Disease Investigation Committee under the auspices of the Japanese Ministry of Health, Labor and Welfare. There were eight hips in stage IIIA disease (collapse of the femoral head less than 3 mm), 19 hips in stage IIIB disease (collapse 3 mm or greater), and seven stage IV disease hips.

Results: All 34 specimens showed histological abnormalities. In eight stage IIIA hips, six hips were mild and two were moderate histological degeneration. In 19 stage IIIB hips, five hips were mild, six were moderate, and eight had severe arthrosis. Seven stage IV hips had severe arthrosis.

Discussion: Although the radiographs cannot demonstrate early degeneration of cartilage, degenerative changes were present in all stage III hips. Histological degenerative changes in stage IIIB hips were more severe than those in stage IIIA hips. These findings should be kept in mind in treating patients with osteonecrosis of the femoral head.